Retatrutide

Retatrutide

Retatrutide is an experimental peptide that acts on three hormone receptors: GLP-1, GIP and glucagon. Research has shown effects on appetite, satiety, blood glucose regulation and energy metabolism, which may contribute to reduced food intake and changes in body weight.

Because retatrutide also activates the GLP-1 receptor, its possible effects on the brain's reward system, food-related motivation and cravings are also relevant to research. The GLP-1 system is connected to brain regions involved in reward and dopamine-related signalling, but retatrutide's direct effects on dopamine in humans have not yet been established.

Retatrutide remains in clinical development and should not be described as an approved treatment for these effects.

For laboratory and research purposes only. Not intended for human consumption. This information is not medical advice.